Global Veterinary Oncology Market, By Animal Type (Companion Animal, Livestock Animal), Therapy Type (Surgery, Combination Therapy, Chemotherapy, Targeted Therapy, Radiology, Immunotherapy), Application (Melanoma, Osteosarcoma (OSA), Canine Lymphoma, Mast Cell Cancer, Multiple Myeloma), Route of Administration (Intravenous, Oral, Other), End-Users (Veterinary Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Global veterinary oncology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 10.70% in the above mentioned forecast period.
Veterinary oncology includes cancer therapies for the animals. The aim is to permanently eradicate the cancer cells prevalent in the pets. It includes specific treatments such as combination therapy, chemotherapy, targeted therapy, radiology and immunotherapy depending upon the nature, type and stage of the cancer.
Rise in the prevalence of cancer in pets, rise in the investment for research in the pet cancer, growing focus on animal safety, rising importance of pet’s medical care and widespread adoption of pets are the factors that will expand the veterinary oncology market. Rise in the research and development activities in this field and increase in the awareness related to animal healthcare will provide beneficial opportunities for the veterinary oncology market in the forecast period of 2021-2028.
However, high cost of pet cancer treatment, less awareness about pet diseases and adverse effects associated with the pet cancer treatment are the factors that will hinder the market growth and will further challenge the veterinary oncology market in the forecast period mentioned above.
This veterinary oncology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary oncology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Veterinary Oncology Market Scope and Market Size
The veterinary oncology market is segmented on the basis of animal type, therapy type, application, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of animal type, the veterinary oncology market is segmented into companion animal and livestock animal. Companion Animal has been further sub-segmented into equine, canine and feline.
- On the basis of therapy type, the veterinary oncology market is segmented into surgery, combination therapy, chemotherapy, targeted therapy, radiology and immunotherapy.
- On the basis of application, the veterinary oncology market is segmented into melanoma, osteosarcoma (OSA), canine lymphoma, mast cell cancer and multiple myeloma.
- On the basis of route of administration, the veterinary oncology market is segmented into intravenous, oral and others.
- On the basis of end-users, the veterinary oncology market is segmented into veterinary clinic, hospital and others.
- The veterinary oncology market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Veterinary Oncology Market Country Level Analysis
Veterinary oncology market is analyzed and market size information is provided by the country, type, therapy type, application, route of administration, end-users and distribution channel as referenced above.
The countries covered in the veterinary oncology market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the veterinary oncology market due to the presence of major key players, well-developed healthcare sector, widespread adoption of pets, and increasing awareness towards health in this region. Asia Pacific and Europe is expected to grow during the forecast period 2021 to 2028 due to the growing importance of medical care, regular medical check-up, establishment of several pet clinics, emerging markets and changing organisation of families.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Veterinary oncology market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Veterinary Oncology Market Share Analysis
Veterinary oncology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to veterinary oncology market.
The major players covered in the veterinary oncology market report are Boehringer Ingelheim International GmbH., Elanco, Zoetis, PetCure Oncology, Accuray Incorporated, Varian Medical Systems, Inc., Nippon Zenyaku Kogyo Co., Ltd., Morphogenesis, Inc., Karyopharm, Regeneus Ltd., VetDC, and Rhizen Pharmaceuticals AG, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.